Last updated on June 2019

A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders


Brief description of study

This study is a phase II of effcicacy and tolerance of azacitidine in patients with myelodysplatic syndrome and steroid dependent or resistent systemic auto-immune and inflammatory disorders

Detailed Study Description

This trial will be a prospective French nationwide study analyzing the effect of treatment with azacitidine in patients with MDS-associated SAID with steroid dependence and/or resistance, and its correlation with possible changes in immunological parameters

Clinical Study Identifier: NCT02985190

Find a site near you

Start Over

CHU Amiens

Amiens cedex 01, France
  Connect »

CH Valence

Valence, France
  Connect »

CHR d'Orl ans

Orléans, France
  Connect »

H pital Archet 1

Nice cedex 3, France
  Connect »

CH Yves Le Foll

Saint-Brieuc, France
  Connect »

CH Ren Dubos

Cergy-Pontoise, France
  Connect »

CHU d'Angers

Angers cedex 9, France
  Connect »

CHU Estaing

Clermont-Ferrand, France
  Connect »

CHSF Gilles de Corbeil

Corbeil-Essonnes, France
  Connect »

CHU de Grenoble

Grenoble cedex 09, France
  Connect »

CH Le Mans

Le Mans cedex 09, France
  Connect »

CH de Mont de Marsan

Mont-de-Marsan, France
  Connect »

CHU de N mes

Nîmes cedex 9, France
  Connect »

CHR d'Orl ans

Orléans, France
  Connect »

IUCT Oncopole

Toulouse, France
  Connect »

CHU Brabois

Vandoeuvre-les-Nancy, France
  Connect »

CHU de N mes

Nîmes cedex 9, France
  Connect »

CHR d'Orl ans

Orléans, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.